Bexarotene

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.1, Iss.4, 2000-07, pp. : 245-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides

By Papadavid Evangelia Antoniou Christina

American Journal of Clinical Dermatology, Vol. 9, Iss. 3, 2008-01 ,pp. : 169-173

Adis International

Access to resources Recommend Favorite

Bexarotene: A Viewpoint by Alain H. Rook, Michael S. Lehrer, Jacqueline M. Junkins-Hopkins, Carmella C. Vittorio, Lars E. French

By Rook A.H. Lehrer M.S. Junkins-Hopkins J.M. Vittorio C.C. French L.E.

American Journal of Clinical Dermatology, Vol. 1, Iss. 4, 2000-07 ,pp. : 251-252

Adis International

Access to resources Recommend Favorite

Mycosis Fungoides with Follicular Mucinosis Displaying Aggressive Tumor-Stage Transformation: Successful Treatment Using Radiation Therapy Plus Oral Bexarotene Combination Therapy

By Apisarnthanarax N.

American Journal of Clinical Dermatology, Vol. 4, Iss. 6, 2003-01 ,pp. : 429-433

Adis International

Access to resources Recommend Favorite